Schedule III continues criminalization ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Dear Friend,

Earlier today, the Trump administration announced the rescheduling of state-regulated medical marijuana products and FDA-approved products containing marijuana as Schedule III substances. All other marijuana remains Schedule I, the most restrictive class.

This would result in tax relief for businesses selling Schedule III products, lift some research barriers, and acknowledge the medical value and relatively low risk of marijuana. The administration will also hold a hearing to consider the broader rescheduling of marijuana.

After years of delays and half-measures, this partial move toward Schedule III still only delivers incremental change. Schedule III continues federal marijuana criminalization.

=====
Urge Congress to deliver the real reform that Americans deserve by descheduling and decriminalizing marijuana [link removed]
=====

Here’s why rescheduling marijuana to Schedule III is not enough:

--Criminalization continues, as do lasting barriers to jobs, food, and housing. Marijuana possession and use remain federal crimes everywhere—regardless of state law. That means arrests, deportations, and the consequences of arrest records will continue.

--Most federal marijuana research roadblocks likely remain. Schedule III may ease some barriers to marijuana research. But it won’t address researchers’ inability to study the marijuana products people actually use.

--Fails to establish a national safety framework. Despite marijuana being legalized for adult use in 24 states and medical use in 40 states, the federal government has not established standards for product safety and regulation, labeling, or worker protections.

--Corporations benefit most. Rescheduling delivers major tax breaks to marijuana companies, but provides little meaningful benefit for consumers, patients, or communities harmed by criminalization.

For decades, our movement—alongside people like you—has fought for marijuana policies that end arrests, protect health, expand economic opportunity, and strengthen communities. Thanks to you, we’ve made real progress. But Schedule III leaves dangerous gaps.

True reform requires Congress to act. By passing comprehensive legislation, Congress can fully remove marijuana from the Controlled Substances Act (CSA), end federal criminal penalties, and create a federal regulatory framework based on public health and fair economic opportunities.

=====
That’s why we need your help urging Congress to pass the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act.: [link removed]
=====

The MORE Act would:

--End federal criminal penalties by decriminalizing marijuana. Criminal penalties can block access to jobs, housing, and other essential needs.

--Advance expungements for those with marijuana convictions. This helps ensure a fair playing field, so everyone has access to jobs and economic opportunities, including those in the marijuana industry.

--Require federal labeling standards. Labeling requirements should provide clear information on potency, ingredients, and safe usage to help consumers make informed decisions.

--Reinvest marijuana tax money into health and addiction services, job training, and public health programs. Funding could support community needs by creating expanded addiction services, reentry programs for people who have been incarcerated, and assistance with housing, employment, and education.

=====
Tell your Representative to sponsor and pass the MORE Act today: [link removed]
=====

Thank you for continuing to stand with us. Together, we’ll keep pushing for marijuana laws that reflect the will of the American people and center health, reinvestment, and fairness for all.

In solidarity,
Drug Policy Alliance

Donate [link removed]

Follow Us
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

You have received this email because [email protected] is a member of the Drug Policy Alliance mailing list.

Copyright © 2026 Drug Policy Alliance. All Rights Reserved.
131 West 33rd St., 15th Floor, New York, NY 10001

Terms and Conditions
[link removed]

Privacy Policy
[link removed]

Email Preferences
[link removed]